Progress Toward Elimination of Haemophilus influenzae Type b Disease among Infants and Children - United States, 1987-1995

Morbidity and Mortality Weekly Report

Volumn 45, Issue 42, 1996, Pages 901-906

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HAEMOPHILUS VACCINE; HIBTITER PROTEIN, HAEMOPHILUS INFLUENZAE;

ARTICLE; BACTERIAL INFECTION; HAEMOPHILUS INFLUENZAE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INCIDENCE; INFANT; PRESCHOOL CHILD; UNITED STATES;

BACTERIAL PROTEINS; CHILD, PRESCHOOL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; INCIDENCE; INFANT; POPULATION SURVEILLANCE; UNITED STATES;

EID: 0030601576     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ward J, Leiberman JM, Cochi SL. Haemophilus influenzae vaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. 2nd ed. Philadelphia, Pennsylvania: WB Saunders Co., 1994;337-86.
2. CDC. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1994;43(no. RR-1).
3. Broome CV. Epidemiology of Haemophilus influenzae type b infections in the United States. Ped Inf Dis J 1987;6:779-82.
4. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
5. CDC. Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1993-1994. MMWR 1995;44:545-50.
6. CDC. Reported vaccine-preventable disease - United States, 1993, and the Childhood Immunization Initiative. MMWR 1994;43:57-60.
7. CDC. Mandatory reporting of infectious diseases by clinicians. MMWR 1990;39(no. RR-9):1-17.
8. CDC. National Electronic Telecommunications System for Surveillance - United States, 1990-1991. MMWR 1991;40:502-3.
9. CDC. National, state, and urban area vaccination coverage levels among children aged 19-35 months - United States, July 1994-June 1995. MMWR 1996;45:508-13.
10. Jafari H, Adams W, Deaver K, Plikaytis B, Wenger J. Efficacy of Haemophilus influenzae type b (Hib) conjugate vaccine, risk factors for invasive Hib disease and under-vaccination in the United States [abstract no. G12]. In: Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1995:160.